Literature DB >> 438784

Neurological soft signs and psychopathology. I. Findings in schizophrenia.

S M Cox, A M Ludwig.   

Abstract

Systematic, standardized evaluations for neurological soft signs were conducted on five psychiatric populations and a control group of medical inpatients. Soft signs were grouped according to their probable clinical association with cortical lobe dysfunction. Preliminary results indicated that schizophrenics, compared to other groups, showed significant increased presence of soft signs presumably related to frontal and parietal lobe dysfunction.

Entities:  

Mesh:

Year:  1979        PMID: 438784     DOI: 10.1097/00005053-197903000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  6 in total

Review 1.  Neuropsychiatric rehabilitation for persistent mental illness.

Authors:  J Jaeger; E Douglas
Journal:  Psychiatr Q       Date:  1992

Review 2.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

3.  Neurological soft signs in schizophrenia: assessment and correlates.

Authors:  F Mohr; W Hubmann; R Cohen; W Bender; C Haslacher; S Hönicke; R Schlenker; C Wahlheim; P Werther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

4.  Neurological soft signs in schizophrenia: a meta-analysis.

Authors:  Raymond C K Chan; Ting Xu; R Walter Heinrichs; Yue Yu; Ya Wang
Journal:  Schizophr Bull       Date:  2009-04-17       Impact factor: 9.306

5.  Comparison of Neurological Soft Signs between Psychotic and Non Psychotic Patients.

Authors:  Abdollah Farhadi Nasab; Bahare Sabbagh Abrishami; Behnaz Ghavami; Seyed Mostafa Hosseini-Zijoud
Journal:  J Clin Diagn Res       Date:  2017-06-01

6.  Neurological soft signs, cognitive dysfunction and ventricular brain ration in schizophrenics.

Authors:  N Lal; S C Tiwari; S Srivastava; A Khalid; N Kohli
Journal:  Indian J Psychiatry       Date:  1998-04       Impact factor: 1.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.